GW Prescribed pills CEO Justin Gover discusses how the corporate secured FDA acclaim for its cannabis-derived drug and what it says about the long term of cannabis-derived pills.
GW Pharma CEO on novel cannabis-derived drug
Tweet on Twitter
Share on Facebook
Pinterest
